Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.045,67
0,20%
NASDAQ Composite
15.646,21
-0,07%
Bitcoin
57.957,36
-4,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aerovate Therapeutics Inc (AVTE) Aerovate Therapeutics Inc (AVTE) Notizie

Aerovate Therapeutics Inc

AVTE
20,775
0,765 (3,82%)
Ultimo aggiornamento: 20:13:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/3/202414:20GLOBEAerovate Therapeutics to Present Patient Baseline..
25/3/202421:10GLOBEAerovate Therapeutics Announces Full-Year 2023 Financial..
11/3/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:37EDGAR2Form 144 - Report of proposed sale of securities
06/3/202414:00GLOBEAerovate Therapeutics Board of Directors Appoints Habib..
28/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202400:38EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
25/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:29EDGAR2Form 144 - Report of proposed sale of securities
08/1/202423:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202413:59EDGAR2Form 8-K - Current report
30/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202323:50EDGAR2Form 144 - Report of proposed sale of securities
23/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:24EDGAR2Form 144 - Report of proposed sale of securities
16/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:10EDGAR2Form 144 - Report of proposed sale of securities
08/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:13EDGAR2Form 144 - Report of proposed sale of securities
20/11/202322:46EDGAR2Form 8-K - Current report
20/11/202322:45GLOBEAerovate Therapeutics Announces Simultaneous Completion of..
13/11/202314:03EDGAR2Form 8-K - Current report
13/11/202314:00GLOBEAerovate Therapeutics Announces Third Quarter Financial..
03/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202320:05EDGAR2Form 144 - Report of proposed sale of securities
14/8/202314:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:10EDGAR2Form 8-K - Current report
14/8/202314:00GLOBEAerovate Therapeutics Announces Second Quarter Financial..
10/8/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202317:53EDGAR2Form 144 - Report of proposed sale of securities
11/7/202323:03EDGAR2Form 8-K - Current report
11/7/202323:00GLOBEAerovate Therapeutics Appoints Habib Dable To Its Board of..
08/7/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202321:35EDGAR2Form 144 - Report of proposed sale of securities
01/6/202314:00GLOBEAerovate Therapeutics to Present at Jefferies Global..
22/5/202319:15GLOBEAerovate Therapeutics Presents Nonclinical Pharmacokinetic..
15/5/202322:05GLOBEAerovate Therapeutics Announces First Quarter Financial..
Apertura: 19,91 Min: 19,73 Max: 20,94
Chiusura: 20,01

La tua Cronologia

NASDAQ
AVTE
Aerovate Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network